Gateway Investment Advisers’s AstraZeneca AZN Stock Holding History

Gateway Investment Advisers’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$304K	Sell	1,604 -335	-17%	-$63K	﹤0.01%	706
2026 Q1	$382K	Sell	1,939 -428	-18%	-$82.5K	﹤0.01%	555
2025 Q4	$435K	Hold	2,367	–	–	﹤0.01%	463
2025 Q3	$363K	Buy	2,367 +30	+1%	+$4.54K	﹤0.01%	445
2025 Q2	$327K	Buy	2,337 +4	+0.2%	+$561	﹤0.01%	411
2025 Q1	$343K	Buy	2,333 +768	+49%	+$111K	﹤0.01%	431
2024 Q4	$205K	Sell	1,565 -877	-36%	-$123K	﹤0.01%	481
2024 Q3	$380K	Hold	2,442	–	–	﹤0.01%	420
2024 Q2	$381K	Hold	2,442	–	–	﹤0.01%	415
2024 Q1	$331K	Sell	2,442 -7,664	-76%	-$1.01M	﹤0.01%	434
2023 Q4	$1.36M	Buy	+10,106	New	+$1.31M	0.02%	296
2022 Q3	–	Sell	-1,676	Closed	-$221K	–	509
2022 Q2	$221K	Hold	1,676	–	–	﹤0.01%	518
2022 Q1	$222K	Buy	+1,676	New	+$201K	﹤0.01%	529

Other funds holding AZN

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

CDDEC

Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

Gateway Investment Advisers's AZN Position: Q2 2026 in Review

Gateway Investment Advisers reduced its AstraZeneca (AZN) stake by 17% in Q2 2026, selling an estimated $63K and leaving 1,604 shares worth $304K. The position accounts for ﹤0.01% of the portfolio, ranked #706.

Gateway Investment Advisers first reported a position in AZN in Q1 2022 and has held it in 13 quarters since. The position peaked at $1.36M in Q4 2023. 443 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Gateway Investment Advisers held 1,604 shares of AstraZeneca worth $304K as of Q2 2026.
Gateway Investment Advisers sold 335 AstraZeneca shares in Q2 2026, an estimated $63K.
AstraZeneca made up ﹤0.01% of Gateway Investment Advisers's portfolio in Q2 2026, its #706 holding.
Gateway Investment Advisers first reported a position in AstraZeneca in Q1 2022 and has held it in 13 quarters since.
Gateway Investment Advisers's AstraZeneca position peaked at $1.36M in Q4 2023.
443 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Gateway Investment Advisers's 13F filing for Q2 2026, filed 20 Jul 2026.